Fagron NV (OTCMKTS:ARSUF – Get Free Report) saw a large drop in short interest during the month of February. As of February 27th, there was short interest totaling 87 shares, a drop of 34.6% from the February 12th total of 133 shares. Based on an average daily trading volume, of 556 shares, the short-interest ratio is presently 0.2 days. Based on an average daily trading volume, of 556 shares, the short-interest ratio is presently 0.2 days.
Fagron Stock Performance
Shares of OTCMKTS ARSUF opened at $27.00 on Friday. Fagron has a twelve month low of $26.00 and a twelve month high of $27.00. The business has a 50 day simple moving average of $26.20 and a 200-day simple moving average of $24.62.
Fagron Company Profile
Fagron (OTCMKTS:ARSUF) is a global pharmaceutical compounding company that supplies raw materials, equipment and services to compounding pharmacies, hospitals and healthcare practitioners. Its portfolio encompasses a range of pharmaceutical ingredients, dosage forms and specialized compounding solutions designed to meet patient-specific needs. The company supports the preparation of customized medications in areas such as dermatology, pain management, hormone replacement therapy and veterinary medicine, providing both sterile and non-sterile compounding products.
Headquartered in Rotterdam, the Netherlands, Fagron operates in more than 55 countries across Europe, the Americas, Asia-Pacific and the Middle East & Africa.
Featured Articles
- Five stocks we like better than Fagron
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- A personal warning from Martin Weiss (Please read)
Receive News & Ratings for Fagron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fagron and related companies with MarketBeat.com's FREE daily email newsletter.
